Clinical Trial Update: Ex Vivo Human Thrombosis Chamber Study [Phase 1]

View source ↗

Summary

Phase 1 ex vivo thrombosis chamber study sponsored by Bristol-Myers Squibb; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Cardiovascular Disease | Phase 1 | Status: COMPLETED